cancer treatment Medical news

Can Acupuncture Wrist Bands Quell Chemotherapy-Related Nausea

Nausea is an adverse side effect that afflicts more than 75 percent of all cancer patients who have undergone chemotherapy. Along with vomiting, this nausea can severely impact a patient’s daily quality of life by hindering the ability to eat and feel healthy. In many cases, doctors may recommend medications as a way to minimize nausea.

However, an effective non-drug nausea treatment may be as simple as slipping a pair of acupuncture bands onto the wrists. These bands, known as BioBands, have been proven to reduce nausea felt during travel sickness by applying pressure to the Nei Kuan pressure point located on the underside of each wrist. According to Carl Nicholson, a spokesperson for BioBands, several studies have also been conducted which show “that BioBands are an effective, natural remedy for chemotherapy nausea.”

To validate these claims, the University of Liverpool plans to initiate the largest study pertaining to the effectiveness BioBands as a treatment option for chemotherapy-induced nausea. The study will include more than 700 participants at nine NHS cancer centers. Participants will include a varying group of cancer patients from all walks of life who suffer from differing types of cancers. The goal is to determine which patient groups are most receptive to the non-drug therapy.

The new study is the first BioBands-related trial initiated by the NHS. Additional funding is provided by the National Institute for Health Research Health Technology Assessment program. The University of Manchester, Salford University and the University of Plymouth will aid in the research process.

Until the research is complete, current cancer patients can safely try BioBands as a home remedy for chemotherapy-induced nausea. For more information or to purchase BioBands, please visit the company’s official website:


Medical news

Experts Optimistic About the Progression Of Mesothelioma Treatment

The International Mesothelioma Interest Group (IMIG) meets on a yearly basis to discuss cutting-edge news related to the deadly cancer known as malignant mesothelioma. Over the past few years, the IMIG has become increasingly confident and optimistic about current and upcoming mesothelioma treatment processes.

Key factors related to effective treatment of mesothelioma that the IMIG sites as important include early detection, reliable diagnosis, initiating proper staging procedures and effective post-treatment monitoring. Many recent advances have become accessible that assist these key aspects of treatment.

One such step is a procedure known as immunohistochemistry (IHC). This relatively new procedure greatly improves the accuracy of malignant mesothelioma diagnosis and has become a standardized step in the process. Imaging tactics have also improved. Researchers are particularly optimistic about CT scan imaging and its ability to deliver more accurate data about tumor size.

The IMIG is also excited about the prospects of screening biological markers. Recent studies have linked certain proteins – such as serum mesothelin-related protein (SMRP) – to an elevated risk for mesothelioma. Using biological markers to search for such proteins is expected to facilitate early detection and monitoring.

As new research findings continue to pour in, doctors and researchers continue to craft more effective ways to identify, treat and monitor malignant mesothelioma. These new tactics are leading the way towards improved survival rates and decreased chemotherapy side effects.